Robert Griffin
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
-
- Computational Drug Discovery Methods
Papers in
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 14
- Oncology 16
- HER2/EGFR in Cancer Research 5
- Drug Transport and Resistance Mechanisms 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Nicola J. Curtin (9 shared papers)Barbara W. Durkacz (2 shared papers)Karen J. Bowman (2 shared papers)Alex W. White (1 shared paper)Hilary Calvert (7 shared papers)Mark D. Carr (3 shared papers)Simon J. Boulton (1 shared paper)Robert A. Bulman (5 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)International Journal of Pharmaceutics (5 papers)Xenobiotica (4 papers)British Journal of Cancer (3 papers)Drug Metabolism and Disposition (3 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Robert Griffin
67 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 93
- Oncology 611
- Computational Theory and Mathematics 189
- Molecular Biology 681
- Pharmacology 103
- Organic Chemistry 303
Countries citing papers authored by Robert Griffin
This map shows the geographic impact of Robert Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Griffin more than expected).
Fields of papers citing papers by Robert Griffin
This network shows the impact of papers produced by Robert Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Griffin. The network helps show where Robert Griffin may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Griffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 331 | |
| 2 | 2013 | 281 | |
| 3 | 2021 | 150 | |
| 4 | 2022 | 127 | |
| 5 | 1998 | 121 | |
| 6 | 1995 | 117 | |
| 7 | 2018 | 116 | |
| 8 | 2020 | 103 | |
| 9 | 2008 | 99 | |
| 10 | 1995 | 86 | |
| 11 | 2004 | 85 | |
| 12 | 2009 | 69 | |
| 13 | 2015 | 63 | |
| 14 | 2003 | 51 | |
| 15 | 2017 | 40 | |
| 16 | 2021 | 40 | |
| 17 | 2009 | 35 | |
| 18 | 2021 | 35 | |
| 19 | 2008 | 33 | |
| 20 | 2018 | 33 |
About Robert Griffin
Robert Griffin is a scholar working on Pharmacology, Oncology, Organic Chemistry, Inorganic Chemistry and Pharmaceutical Science, having authored 71 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Synthesis and biological activity (9 papers), Pesticide Exposure and Toxicity (6 papers), Lung Cancer Treatments and Mutations (5 papers), Radioactive element chemistry and processing (5 papers), HER2/EGFR in Cancer Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Oncology (611 citations), Computational Theory and Mathematics (189 citations), Molecular Biology (681 citations), Pharmacology (103 citations) and Organic Chemistry (303 citations). Robert Griffin has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Nicola J. Curtin, Barbara W. Durkacz, Karen J. Bowman, Alex W. White, Hilary Calvert, Mark D. Carr, Simon J. Boulton, Robert A. Bulman, Michael L. Cunningham and Václav Veverka. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, International Journal of Pharmaceutics, Xenobiotica, British Journal of Cancer and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.